Paweł Mróz
- Pulmonary and Respiratory Medicine top 0.1%
- Photodynamic Therapy Research Studies 40
- Biomedical Engineering top 0.1%
- Nanoplatforms for cancer theranostics 38
- Materials Chemistry top 1%
- Porphyrin and Phthalocyanine Chemistry 9
- Biotechnology top 1%
- Cancer Research and Treatments 9
- Biomaterials top 2%
-
- Immunotherapy and Immune Responses 11
-
- Ocular Infections and Treatments 5
-
- Cancer, Hypoxia, and Metabolism 4
-
- Acute Myeloid Leukemia Research 3
- Co-authors
- Michael R. HamblinAna P. CastañoJakub GołąbDominika NowisJohan MoanPatrizia AgostinisJacques PietteSandra O. Gollnick
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesPolandJapan
In The Last Decade
Paweł Mróz
57 papers receiving 10.0k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Pulmonary and Respiratory Medicine 6.5k
- Biomedical Engineering 7.5k
- Materials Chemistry 4.0k
- Biotechnology 492
- Biomaterials 633
Countries citing papers authored by Paweł Mróz
This map shows the geographic impact of Paweł Mróz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Mróz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Mróz more than expected).
Fields of papers citing papers by Paweł Mróz
This network shows the impact of papers produced by Paweł Mróz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Mróz. The network helps show where Paweł Mróz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paweł Mróz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2021 | 18 | |
| 4 | 2019 | 7 | |
| 5 | 2013 | 52 | |
| 6 | 2012 | 30 | |
| 7 | 2012 | 80 | |
| 8 | Photodynamic therapy of cancer: An updatebreakdown → | 2011 | 4317 |
| 9 | 2011 | 75 | |
| 10 | 2011 | 51 | |
| 11 | 2010 | 117 | |
| 12 | 2010 | 17 | |
| 13 | 2010 | 84 | |
| 14 | 2010 | 209 | |
| 15 | 2009 | 109 | |
| 16 | 2008 | 96 | |
| 17 | 2007 | 238 | |
| 18 | Photodynamic therapy and anti-tumour immunitybreakdown → | 2006 | 2285 |
| 19 | Mechanizmy indukcji apoptozy i zastosowanie TRAIL w terapii nowotworow. | 2003 | 2 |
| 20 | 2003 | 4 |
About Paweł Mróz
Paweł Mróz is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Biomedical Engineering, having authored 59 papers that have together received 10.1k indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (40 papers), Nanoplatforms for cancer theranostics (38 papers), Immunotherapy and Immune Responses (11 papers), Cancer Research and Treatments (9 papers), Porphyrin and Phthalocyanine Chemistry (9 papers), Ocular Infections and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.5k citations), Biomedical Engineering (7.5k citations) and Materials Chemistry (4.0k citations). Paweł Mróz has collaborated with scholars based in United States, Poland and Japan. Frequent co-authors include Michael R. Hamblin, Ana P. Castaño, Jakub Gołąb, Dominika Nowis, Johan Moan, Patrizia Agostinis, Jacques Piette, Sandra O. Gollnick, Mladen Korbelik and Stephen M. Hahn. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.